[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] # Arcellx, Inc. Common Stock (ACLX) Arcellx shares surge following positive Phase X trial data for anito-cel in multiple myeloma, with analysts reiterating buy ratings and price targets around $105-$130. ### About Arcellx, Inc. Common Stock Arcellx, Inc. is a biopharmaceutical company focused on developing novel cancer therapies. Arcellx, Inc. Common Stock uses the ticker $ACLX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights - Arcellx, Inc. Common Stock (ACLX) social dominance hit XXXXXX which is XXX% higher than it's daily average. - Arcellx, Inc. Common Stock (ACLX) social dominance near a 52-week high at XXXXXX. - Arcellx, Inc. Common Stock (ACLX) trading volume is up XXXXXX% from the previous week. - Arcellx, Inc. Common Stock (ACLX) social dominance is up 1689.8% from the previous week. - Arcellx, Inc. Common Stock (ACLX) Galaxy Score™ is up XXXXX% from the previous month. - Arcellx, Inc. Common Stock (ACLX) creators is up XXXXXX% from the previous month. - Arcellx, Inc. Common Stock (ACLX) engagements is up XXXXXX% from the previous month. - Arcellx, Inc. Common Stock (ACLX) mentions is up XXXXXX% from the previous month. - Arcellx, Inc. Common Stock (ACLX) posts created is up XXXXXX% from the previous week. - Arcellx, Inc. Common Stock Engagements hit a 52-Week high of XXXXXX for the day ### Price: $XXXXX  [Price 24-Hour Time-Series Raw Data](/topic/$aclx/time-series/close.tsv) The stock price is experiencing upward pressure due to positive Phase X trial data and analyst upgrades, despite some concerns about overall engagement levels. 24-Hour: -XXXX% 7-Day: XXX% 30-Day: -XXXXX% 1-Year High: $XXXXX on 2025-10-15 1-Year Low: $XXXXX on 2025-05-06 ### AltRank: XXX  [AltRank 24-Hour Time-Series Raw Data](/topic/$aclx/time-series/alt_rank.tsv) Arcellx, Inc. Common Stock (ACLX) is currently AltRank #503 based on combined combined social and market metrics Daily Average: XXXXX X Week: XXX -XXX X Month: XXX -XXX X Months: XXX -XXX X Year: XXX -XXX 1-Year High: XXXXX on 2025-07-18 1-Year Low: XX on 2025-05-29 ### Galaxy Score: XXXXX  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$aclx/time-series/galaxy_score.tsv) Current Value: XXXXX Daily Average: XX X Week: XX +6 X Month: XX +19 X Months: XX -XX X Year: XX -X 1-Year High: XX on 2025-03-03 1-Year Low: XX on 2025-07-19 ### Engagements: XXXXXX (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$aclx/time-series/interactions.tsv) Current Value: XXXXXX Daily Average: XXXXX X Week: XXXXXX +89% X Month: XXXXXXX +556% X Months: XXXXXXX -XX% X Year: XXXXXXXXX +5.90% 1-Year High: XXXXXX on 2025-12-07 1-Year Low: XX on 2025-09-15 Engagements by network (24h): Reddit: XX X: XXXXXX YouTube: XX ### Mentions: XXX (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$aclx/time-series/posts_active.tsv) Current Value: XXX Daily Average: XX X Week: XXX +48% X Month: XXX +113% X Months: XXXXX +32% X Year: XXXXX +77% 1-Year High: XXX on 2025-06-29 1-Year Low: X on 2025-09-15 Mentions by network (24h): Reddit: XX X: XXXXX YouTube: X ### Creators: XX (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$aclx/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning Arcellx, Inc. Common Stock (ACLX) in the last XX hours which is down XX% from XXX in the previous XX hours Daily Average: XX X Week: XXX +56% X Month: XXX +107% X Months: XXXXX +101% X Year: XXXXX +109% 1-Year High: XXX on 2025-06-29 1-Year Low: X on 2025-09-14 The most influential creators that mention Arcellx, Inc. Common Stock in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@JacobPlieth](/creator/twitter/JacobPlieth) | X | XXXXXX | X | XXXXX | | [@BiopharmIQ](/creator/twitter/BiopharmIQ) | X | XXXXXX | X | XXX | | [@adamfeuerstein](/creator/twitter/adamfeuerstein) | X | XXXXXXX | X | XXX | | [@FrenzyCapital](/creator/twitter/FrenzyCapital) | X | XXXXX | X | XXX | | [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) | X | XXXXX | X | XXX | | [@semodough](/creator/twitter/semodough) | X | XXXXXX | X | XXX | | [@arcellx](/creator/twitter/arcellx) | X | XXX | X | XXX | | [@Pelegggg](/creator/twitter/Pelegggg) | X | XX | X | XXX | | [@Quantumup1](/creator/twitter/Quantumup1) | X | XXXXX | X | XX | | [@DwightS2025](/creator/twitter/DwightS2025) | XX | XXX | X | XX | [View More](/list/creators/$aclx/100) ### Sentiment: XX%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$aclx/time-series/sentiment.tsv) Current Value: XX% Daily Average: XX% X Week: XX% no change X Month: XX% -X% X Months: XX% +3% X Year: XX% +4% 1-Year High: XXX% on 2025-07-13 1-Year Low: XX% on 2025-09-18 Most Supportive Themes: - Analyst Coverage: (40%) Analysts are increasing their target prices and initiating buy ratings for Arcellx, Inc. - FDA Pre-BLA Meeting & 2026 Launch Plan: (30%) Arcellx has completed a pre-BLA meeting with the FDA, confirming their 2026 launch plan for anito-cel. - Phase X Data Presentation: (20%) Arcellx will present Phase X multiple myeloma results for anitocabtagene autoleucel at ASH 2025. Most Critical Themes: - Lower Engagement: (10%) Despite positive sentiment, overall engagement is lower than the daily average. ### Social Dominance: XXXXX%  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$aclx/time-series/social_dominance.tsv) Current Value: XXXXX% Daily Average: XXXXX% X Week: XXXXX% +0.083% X Month: XXXX% +0.055% X Months: XXXX% +0.051% X Year: XXXX% +0.033% 1-Year High: XXXXX% on 2024-12-21 1-Year Low: XXXXXX% on 2025-09-15 ### Market Dominance: XXXXXXX%  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$aclx/time-series/market_dominance.tsv) Current Value: XXXXXXX% Daily Average: X% 1-Year High: XXXXXXX% on 2025-03-12 1-Year Low: XXXXXXX% on 2025-05-06 ### Market Cap: $XXXXXXXXXXXXX  [Market Cap 24-Hour Time-Series Raw Data](/topic/$aclx/time-series/market_cap.tsv) Current Value: $XXXXXXXXXXXXX Daily Average: $XXXXXXXXXXXXX X Week: $XXXXXXXXXXXXX +$5.20% X Month: $XXXXXXXXXXXXX -$18% X Months: $XXXXXXXXXXXXX +$12% X Year: $XXXXXXXXXXXXX -$8.70% 1-Year High: $XXXXXXXXXXXXX on 2025-11-17 1-Year Low: $XXXXXXXXXXXXX on 2025-05-06 ### Top Arcellx, Inc. Common Stock Social Posts Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "ive got a good feeling about $VERV and $RNA. im thinking $LLY and $NVS" [X Link](https://x.com/PersimmonTI/status/1998484020724904215) [@PersimmonTI](/creator/x/PersimmonTI) 2025-12-09T20:04Z 10.5K followers, 5557 engagements "What a stinker of an #ASH25 for $ACLX -XX% since Nov abstract drop. Inconsequential Immagine-1 update while others making huge strides" [X Link](https://x.com/JacobPlieth/status/1998445251929702548) [@JacobPlieth](/creator/x/JacobPlieth) 2025-12-09T17:30Z 31.3K followers, 4211 engagements "@ablT315I And. here come the sellside notes defending $ACLX" [X Link](https://x.com/JacobPlieth/status/1998441028085338596) [@JacobPlieth](/creator/x/JacobPlieth) 2025-12-09T17:14Z 31.3K followers, XXX engagements "$ACLX Guys Don't miss the Target price for Next Week" [X Link](https://x.com/HollPabla39969/status/1998434780610965991) [@HollPabla39969](/creator/x/HollPabla39969) 2025-12-09T16:49Z XX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Arcellx shares surge following positive Phase X trial data for anito-cel in multiple myeloma, with analysts reiterating buy ratings and price targets around $105-$130.
Arcellx, Inc. is a biopharmaceutical company focused on developing novel cancer therapies.
Arcellx, Inc. Common Stock uses the ticker $ACLX for trading. Listed in the Stocks category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The stock price is experiencing upward pressure due to positive Phase X trial data and analyst upgrades, despite some concerns about overall engagement levels.
24-Hour: -XXXX% 7-Day: XXX% 30-Day: -XXXXX%
1-Year High: $XXXXX on 2025-10-15
1-Year Low: $XXXXX on 2025-05-06
AltRank 24-Hour Time-Series Raw Data
Arcellx, Inc. Common Stock (ACLX) is currently AltRank #503 based on combined combined social and market metrics
Daily Average: XXXXX
X Week: XXX -XXX
X Month: XXX -XXX
X Months: XXX -XXX
X Year: XXX -XXX
1-Year High: XXXXX on 2025-07-18
1-Year Low: XX on 2025-05-29
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +6
X Month: XX +19
X Months: XX -XX
X Year: XX -X
1-Year High: XX on 2025-03-03
1-Year Low: XX on 2025-07-19
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXX
X Week: XXXXXX +89%
X Month: XXXXXXX +556%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX +5.90%
1-Year High: XXXXXX on 2025-12-07
1-Year Low: XX on 2025-09-15
Engagements by network (24h): Reddit: XX X: XXXXXX YouTube: XX
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XX
X Week: XXX +48%
X Month: XXX +113%
X Months: XXXXX +32%
X Year: XXXXX +77%
1-Year High: XXX on 2025-06-29
1-Year Low: X on 2025-09-15
Mentions by network (24h): Reddit: XX X: XXXXX YouTube: X
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Arcellx, Inc. Common Stock (ACLX) in the last XX hours which is down XX% from XXX in the previous XX hours
Daily Average: XX
X Week: XXX +56%
X Month: XXX +107%
X Months: XXXXX +101%
X Year: XXXXX +109%
1-Year High: XXX on 2025-06-29
1-Year Low: X on 2025-09-14
The most influential creators that mention Arcellx, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @JacobPlieth | X | XXXXXX | X | XXXXX |
| @BiopharmIQ | X | XXXXXX | X | XXX |
| @adamfeuerstein | X | XXXXXXX | X | XXX |
| @FrenzyCapital | X | XXXXX | X | XXX |
| @AponiaAnalytics | X | XXXXX | X | XXX |
| @semodough | X | XXXXXX | X | XXX |
| @arcellx | X | XXX | X | XXX |
| @Pelegggg | X | XX | X | XXX |
| @Quantumup1 | X | XXXXX | X | XX |
| @DwightS2025 | XX | XXX | X | XX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% no change
X Month: XX% -X%
X Months: XX% +3%
X Year: XX% +4%
1-Year High: XXX% on 2025-07-13
1-Year Low: XX% on 2025-09-18
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.083%
X Month: XXXX% +0.055%
X Months: XXXX% +0.051%
X Year: XXXX% +0.033%
1-Year High: XXXXX% on 2024-12-21
1-Year Low: XXXXXX% on 2025-09-15
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXXXX% on 2025-03-12
1-Year Low: XXXXXXX% on 2025-05-06
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$5.20%
X Month: $XXXXXXXXXXXXX -$18%
X Months: $XXXXXXXXXXXXX +$12%
X Year: $XXXXXXXXXXXXX -$8.70%
1-Year High: $XXXXXXXXXXXXX on 2025-11-17
1-Year Low: $XXXXXXXXXXXXX on 2025-05-06
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"ive got a good feeling about $VERV and $RNA. im thinking $LLY and $NVS"
X Link @PersimmonTI 2025-12-09T20:04Z 10.5K followers, 5557 engagements
"What a stinker of an #ASH25 for $ACLX -XX% since Nov abstract drop. Inconsequential Immagine-1 update while others making huge strides"
X Link @JacobPlieth 2025-12-09T17:30Z 31.3K followers, 4211 engagements
"@ablT315I And. here come the sellside notes defending $ACLX"
X Link @JacobPlieth 2025-12-09T17:14Z 31.3K followers, XXX engagements
"$ACLX Guys Don't miss the Target price for Next Week"
X Link @HollPabla39969 2025-12-09T16:49Z XX followers, XX engagements
/topic/$aclx